Fludarabine, Cyclophosphamide, and Rituximab in Treating Patients With Prolymphocytic Leukemia

Clinical trial NCT00281931 · TERMINATED

Trial details

NCT number: NCT00281931
Sponsor: German CLL Study Group
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Prolymphocytic Leukemia

Start date: 1999-09-01
Primary completion: 2006-04-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.